AOD-9604 vs GLP-1 S GLP-1 S (semaglutide) works through an entirely different system than AOD-9604: it activates GLP-1 receptors to slow gastric emptying, increase satiety, and improve glycemic control, producing weight loss primarily by reducing food intake rather than by acting on fat cells directly
No immunogenic responses
The foundational obesity finding comes from Kraus and colleagues (Nature, 2014), who showed that knocking down NNMT protected mice against diet-induced obesity establishing NNMT as a metabolic target in the first place
This includes kids, older adults, pregnant and nursing moms, and those with kidney or liver problems
It also means the dosing window is more flexible than peptides that require precise timing around growth hormone release patterns
As you explore its myriad potentials, always prioritize your health, do your due diligence, and seek expert counsel to ensure optimal outcomes